KIR2DL3 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3)

2012-01-01  

Identity

HGNC
LOCATION
19q13.42
LOCUSID
ALIAS
CD158B2,CD158b,GL183,KIR-023GB,KIR-K7b,KIR-K7c,KIR2DL,KIR2DS5,KIRCL23,NKAT,NKAT2,NKAT2A,NKAT2B,p58

Other Information

Locus ID:

NCBI: 3804
MIM: 604938
HGNC: 6331
Ensembl: ENSG00000243772

Variants:

dbSNP: 3804
ClinVar: 3804
TCGA: ENSG00000243772
COSMIC: KIR2DL3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000243772ENST00000342376P43628
ENSG00000243772ENST00000342376E3NZD8

Expression (GTEx)

0
1
2
3
4

Pathways

PathwaySourceExternal ID
Antigen processing and presentationKEGGko04612
Natural killer cell mediated cytotoxicityKEGGko04650
Graft-versus-host diseaseKEGGko05332
Antigen processing and presentationKEGGhsa04612
Natural killer cell mediated cytotoxicityKEGGhsa04650
Graft-versus-host diseaseKEGGhsa05332
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933

References

Pubmed IDYearTitleCitations
152976762004HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.402
183222062008Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.148
209352242010Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.80
200775642010Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.64
200775642010Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.64
198376912009Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.53
199342972009KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.50
219315402011IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.47
158791582005Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.46
182896782008Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome.42

Citation

Dessen P

KIR2DL3 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3)

Atlas Genet Cytogenet Oncol Haematol. 2012-01-01

Online version: http://atlasgeneticsoncology.org/gene/43615/kir2dl3